AlzeCure is part of the region’s world-leading research in healthy aging

Invest Stockholm has now updated its presentation of the region’s research and the companies working with neurodegenerative diseases. Here you will find, among others, AlzeCure, which is developing a painkiller based on this year’s Nobel Prize in Medicine.

Stockholm-Uppsala holds world-leading knowledge in the field of healthy aging. Invest Stockholm has made an extensive review of the region’s academic research in an updated report that also includes several selected companies.

Here is one of Flemingsberg’s knowledge companies: AlzeCure, which develops new innovative drug therapies for the treatment of severe diseases that affect the central nervous system, such as Alzheimer’s disease and pain.

The company is developing a painkiller based on a discovery by David Julius and Ardem Patapoutian who share this year’s Nobel Prize in Physiology or Medicine.

Read more about AlzeCure and the region’s leading research in the report: Improving Quality of Life for People with Neurodegenerative Diseases (pdf).

Flemingsberg became part of a global hackathon

Today, Flemingsberg is one of Stockholm’s most exciting meeting places for creators, entrepreneurs, researchers and innovators. Through the Hack-Nation Global AI Hackathon, Flemingsberg became one of a select number of locations around the world where participants built solutions side by side as part of a global innovation event that brought together thousands of participants from more than 100 countries.

Stockholm region’s only GameTech hub is being built in Flemingsberg

In September this year, Press Start took the next step in developing the Stockholm region’s GameTech ecosystem. Since then, the community has continued to grow, more studios have joined, and work on the next major initiative has gained momentum. So, what has happened so far, and what comes next?

CSIB: New interdisciplinary center brings research together to tackle future infectious threats

Center for Systems Infection Biology (CSIB) was recently inaugurated at Campus Flemingsberg. The new interdisciplinary initiative brings together research, advanced infrastructure and expertise to deepen the understanding of infectious diseases and accelerate the path from research to clinical application. We met with Director Ujjwal Neogi and Co-director Iva Filipovic to talk about the center’s goals, its strong focus on collaboration, and its ambition to contribute to pandemic preparedness.

AlzeCure is part of the region’s world-leading research in healthy aging

Invest Stockholm has now updated its presentation of the region’s research and the companies working with neurodegenerative diseases. Here you will find, among others, AlzeCure, which is developing a painkiller based on this year’s Nobel Prize in Medicine.

Flemingsberg became part of a global hackathon

Stockholm region’s only GameTech hub is being built in Flemingsberg

CSIB: New interdisciplinary center brings research together to tackle future infectious threats

Do you want to know more?
Subscribe to our newsletter.

Do you want to know more?
Subscribe to our newsletter.

AlzeCure is part of the region’s world-leading research in healthy aging

Invest Stockholm has now updated its presentation of the region’s research and the companies working with neurodegenerative diseases. Here you will find, among others, AlzeCure, which is developing a painkiller based on this year’s Nobel Prize in Medicine.

Flemingsberg became part of a global hackathon

Stockholm region’s only GameTech hub is being built in Flemingsberg

CSIB: New interdisciplinary center brings research together to tackle future infectious threats

Do you want to know more? Subscribe to our newsletter.

Do you want to know more? Subscribe to our newsletter.

Do you want to know more?
Subscribe to our newsletter.

Do you want to know more?
Subscribe to our newsletter.